ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Targeting Childhood Brain Cancer in a Dish to Catalyze New Therapies | University of California, Davis Medical Center / Paul Knoepfler, PhD | Innovation Grants | 2017 | California |
Development of MicroRNA-Nanoparticles to Treat Childhood Acute Leukemia Carrying MLL Rearrangements | University of Cincinnati College of Medicine / Jianjun Chen, PhD | Innovation Grants | 2013 | Ohio |
Role of LMO1 in Neuroblastoma Initiation and Maintenance: Analysis in the Zebrafish model of Childhood Neuroblastoma | Dana-Farber Cancer Institute / Thomas Look, M.D. | Innovation Grants | 2014 | Massachusetts |
Norepinephrine Transporter-Targeted Pharmacotherapy of Aggressive Neuroblastoma | Children’s Hospital of Philadelphia / Michael Chorny, PhD | Innovation Grants | 2019 | Pennsylvania |
Molecular Landscape for Targeted Therapy in Retinoblastoma | University of Miami / James Harbour, MD | Innovation Grants | 2018 | Florida |
Targeted nanoparticle-mediated “cold”-to-“hot” reprogramming of the tumor microenvironment of high-risk neuroblastoma | University of Massachusetts Chan Medical School / Prabhani Atukorale, PhD & Jason Shohet, MD, PhD | Innovation Grants | 2022 | Massachusetts |
Loss of ER-mitochondria contacts drives therapy resistance in neuroblastoma | Children’s Hospital of Philadelphia / Michael Hogarty, MD | Innovation Grants | 2021 | Pennsylvania |
Developing a Novel Tumor Model to Screen for New Therapies for Spinal Ependymoma | The Johns Hopkins University School of Medicine / Linda Resar, MD & Richard Schlegel, MD, PhD | Innovation Grants | 2015 | Maryland |
Pediatric Osteosarcoma: Identifying the elusive molecular signature and its relationship to this disease | St. Jude Children’s Research Hospital / Linda Hendershot, PhD | Innovation Grants | 2019 | Tennessee |
BH3 profiling to define therapy resistance classes in neuroblastoma. | Children’s Hospital of Philadelphia / Michael Hogarty | Innovation Grants | 2009 | Pennsylvania |